Skip to main content
Equibles

Virtu Financial LLC

Position in DMRA — Damora Therapeutics, Inc.

CIK 1533964 New York, NY
Back to DMRA Full portfolio

Position in DMRA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$202,851
+$154,015 QoQ
Shares Held
7,799
-40.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 104 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DMRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Virtu Financial LLC holds $37,834,089 across 147 Biotechnology names. DMRA ranks #44 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 58,459 $4,130,128
2 APGE
Apogee Therapeutics, Inc.
 29,790 $3,954,026
3 ABVX
Abivax S.A.
 19,155 $2,552,595
4 AXSM
Axsome Therapeutics, Inc.
 9,220 $2,256,779
5 KYMR
Kymera Therapeutics, Inc.
 12,556 $1,439,796
6 PTGX
Protagonist Therapeutics, Inc
 8,163 $1,000,620
7 TGTX
Tg Therapeutics, Inc.
 17,524 $962,768
8 IOVA
Iovance Biotherapeutics, Inc.
 221,500 $921,440

All Filings in DMRA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $202,851 7,799
2025-09-30 $48,836 13,128